Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

West Pharmaceutical Services 530 HERMAN O. WEST DRIVE EXTON PA 19341 USA

www.westpharma.com Employees: 10,600 P: 610-594-2900

Sector:

Medical

Description:

West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.

Key Statistics

Overview:

Market Capitalization, $K 17,560,882
Enterprise Value, $K 16,972,382
Shares Outstanding, K 72,021
Float, K 71,639
% Float 99.47%
Short Interest, K 2,560
Short Float 3.55%
Days to Cover 1.92
Short Volume Ratio 0.69
% of Insider Shareholders 0.53%
% of Institutional Shareholders 93.90%

Financials:

Annual Sales, $ 3,074 M
Annual Net Income, $ 493,700 K
Last Quarter Sales, $ 805,000 K
Last Quarter Net Income, $ 132,100 K
EBIT, $ 584,900 K
EBITDA, $ 756,300 K

Growth:

1-Year Return 18.40%
3-Year Return -21.41%
5-Year Return -13.12%
5-Year Revenue Growth 43.19%
5-Year Earnings Growth 53.15%
5-Year Dividend Growth 30.77%

Per-Share Information:

Most Recent Earnings 2.04 on 02/12/26
Next Earnings Date 04/23/26
Earnings Per Share ttm 7.29
EPS Growth vs. Prev Qtr 4.08%
EPS Growth vs. Prev Year 12.09%
Annual Dividend & Yield (Paid) 0.86 (0.35%)
Annual Dividend & Yield (Fwd) 0.88 (0.35%)
Most Recent Dividend 0.220 on 01/28/26
Next Ex-Dividends Date 04/29/26
Dividend Payable Date 05/06/26
Dividend Payout Ratio 11.54%
Most Recent Split 2-1 on 09/27/13

WST Ratios

Ratio
Price/Earnings ttm 34.05
Price/Earnings forward 30.94
Price/Earnings to Growth 2.63
Return-on-Equity % 17.90%
Return-on-Assets % 13.29%
Profit Margin % 16.06%
Debt/Equity 0.06
Price/Sales 5.82
Price/Cash Flow 25.50
Price/Book 5.63
Book Value/Share 44.15
Interest Coverage 2.35
60-Month Beta 1.18

WST Dividends

Date Value
01/28/26 $0.2200
11/12/25 $0.2200
07/30/25 $0.2100
04/30/25 $0.2100
02/07/25 $0.2100
11/13/24 $0.2100
07/31/24 $0.2000
04/23/24 $0.2000
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar